Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NAK | SCZM |
|---|---|---|
| Price | $1.19 | $8.45 |
| Change today | ▼ 8.46% | ▼ 5.69% |
| Market cap | $668.92M | $785.77M |
| Return, 3 months | -30.8% | +26.7% |
| Return, year to date | -39.6% | -12.5% |
| Return, 1 year | -39.0% | +15.4% |
| P/E (TTM) | -14.2 | 18.8 |
| P/B | 85.0 | 3.7 |
| P/E percentile vs own 5y | 28th | 65th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +54.8% |
| Net profit growth (YoY) | -203.7% | -90.4% |
| Gross margin | – | 35.5% |
| Operating margin | – | 28.0% |
| Net margin | – | 10.0% |
| Return on equity | -261.3% | 22.5% |
| Analyst target vs. price | +110.1% | +100.8% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 31 | 43 |
| 30-day volatility | 60.4% | 74.7% |
| Max drawdown, 1 year | -59.1% | -63.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
